• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    83 Biggest Movers From Yesterday

    6/9/22 5:44:29 AM ET
    $ACLX
    $ADTH
    $AERC
    $AMLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Computer Software: Programming Data Processing
    Technology
    Get the next $ACLX alert in real time by email

    Gainers

    • Symbotic Inc. (NASDAQ:SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) shares jumped 114.7% to close at $2.19 on Wednesday after the company authorized a $3.5 million buyback.
    • India Globalization Capital, Inc. (NYSE:IGC) gained 93.5% to close at $0.82. India Globalization Capital was granted U.S. Patent titled 'Method And Composition For Treating Seizure Disorders (Such As Epilepsy).'
    • Qutoutiao Inc. (NASDAQ:QTT) climbed 71.6% to close at $1.63. Shares of several Chinese companies traded higher after Chinese regulators approved some video games for release, which has increased optimism that the country is easing pressure on its tech sector.
    • VivoPower International PLC (NASDAQ:VVPR) gained 40% to settle at $2.24.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) surged 38.8% to close at $0.2915.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) surged 31.9% to close at $0.48.
    • Youdao, Inc. (NYSE:DAO) climbed 30% to settle at $6.76.
    • Athersys, Inc. (NASDAQ:ATHX) gained 28.4% to close at $0.3827.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) climbed 27.1% to settle at $0.75 after gaining more than 9% on Tuesday.
    • Annovis Bio, Inc. (NYSE:ANVS) jumped 26.9% to close at $13.70.
    • MINISO Group Holding Limited (NYSE:MNSO) climbed 26.8% to close at $6.90.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) gained 24.8% to close at $3.07.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) climbed 24.5% to close at $0.33 after the company announced new SBT-272 data demonstrating improvement in upper motor neuron function in ALS disease model at the Keystone Neurodegeneration Symposium.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) jumped 24.5% to close at $0.5851.
    • Limoneira Company (NASDAQ:LMNR) gained 22.3% to close at $13.91 after the company reported better-than-expected Q2 EPS results.
    • HUTCHMED (China) Limited (NASDAQ:HCM) rose 22% to settle at $11.39.
    • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) gained 22% to close at $14.65. The U.S. Food and Drug Administration recently extended the review of New Drug Application (NDA) by three months, submitted by Amylyx Pharmaceuticals for its lead drug candidate AMX0035 with regard to the treatment of patients with amyotrophic lateral sclerosis (ALS).
    • Rekor Systems, Inc. (NASDAQ:REKR) surged 21.9% to settle at $2.62.
    • Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) jumped 21.6% to close at $0.5594.
    • Cyren Ltd. (NASDAQ:CYRN) gained 21.4% to close at $2.16 after the company entered into an agreement with Content Services Group to sell all equity interests in its legacy secure email gateway business.
    • OneConnect Financial Technology Co., Ltd. (NASDAQ:OCFT) rose 21.2% to close at $1.60 after the company board approved to upsize its share repurchase program.
    • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) gained 20.6% to settle at $1.29.
    • Nutex Health, Inc. (NASDAQ:NUTX) rose 20.6% to close at $8.03.
    • ContraFect Corporation (NASDAQ:CFRX) gained 20% to settle at $3.90. WBB Securities upgraded ContraFect from Buy to Strong Buy and announced a $7 price target.
    • Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) jumped 20% to close at $0.2394.
    • Quotient Limited (NASDAQ:QTNT) surged 19.5% to close at $0.4184.
    • Quotient and Theradiag announced partnership To 'advance autoimmune disease diagnostics.'
    • I-Mab (NASDAQ:IMAB) gained 19.4% to close at $10.76. I-Mab announced completion of patient enrollment in Phase III clinical trial of eftansomatropin alfa for treatment of pediatric growth hormone deficiency.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) rose 19.4% to settle at $2.15.
    • Exscientia plc (NASDAQ:EXAI) jumped 19.3% to settle at $15.97.
    • Scienjoy Holding Corporation (NASDAQ:SJ) gained 19.1% to close at $3.00.
    • Dingdong (Cayman) Limited (NASDAQ:DDL) rose 18.9% to settle at $5.54.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) climbed 18.7% to close at $5.01.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) rose 18.6% to settle at $0.7990.
    • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) gained 18.5% to settle at $1.54.
    • Exicure, Inc. (NASDAQ:XCUR) shares gained 18.5% to settle at $0.1339 after declining around 6% on Tuesday.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) jumped 18.5% to close at $5.70.
    • Energy Focus, Inc. (NASDAQ:EFOI) shares rose 18.4% to close at $2.70 after jumping more than 46% on Tuesday. The company recently announced a $3.5 million private placement priced at-the-market under Nasdaq rules.
    • Lannett Company, Inc. (NYSE:LCI) gained 18.4% to settle at $0.6901.
    • DBV Technologies S.A. (NASDAQ:DBVT) jumped 18.3% to close at $1.81 after the company reported topline results from its Phase 3 EPITOPE trial and said the trial met the primary endpoint.
    • CTI BioPharma Corp. (NASDAQ:CTIC) climbed 17.6% to close at $6.27.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) gained 17.1% to settle at $0.2342.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) gained 17% to close at $1.24.
    • 17 Education & Technology Group Inc. (NASDAQ:YQ) jumped 17% to close at $2.82.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) gained 16.9% to close at $0.7599.
    • Austin Gold Corp. (NYSE:AUST) surged 16.4% to close at $1.99.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 16.1% to close at $9.93.
    • Pluristem Therapeutics Inc. (NASDAQ:PSTI) jumped 16% to settle at $1.45.
    • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) gained 15.7% to close at $1.18.
    • BeyondSpring Inc. (NASDAQ:BYSI) surged 15.5% to close at $2.16.
    • Gaotu Techedu Inc. (NYSE:GOTU) rose 15% to close at $1.84. Gaotu Techedu recently announced Q1 earnings results.
    • Alibaba Group Holding Limited (NYSE:BABA) jumped 14.7% to settle at $119.62. The rally came on investor hopes the Chinese government will continue to ease pressure on its tech companies increased after its National Press and Publication Administration approved 60 video games for computers and smartphones.
    • SQL Technologies Corp. (NASDAQ:SKYX) gained 14.4% to close at $2.39.
    • Arcellx, Inc. (NASDAQ:ACLX) climbed 12.8% to settle at $19.16.
    • Katapult Holdings, Inc. (NASDAQ:KPLT) gained 12.5% to close at $13.70.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) gained 11.9% to close at $5.54 after reporting Q1 results. Kingsoft Cloud reported first-quarter FY22 revenue growth of 19.9% year-on-year to $342.9 million, beating the consensus of $312.2 million.
    • SRAX, Inc. (NASDAQ:SRAX) rose 11.7% to close at $4.02. SRAX recently reported fourth-quarter FY21 Sequire revenue growth of 170% year-on-year to $9.6 million, missing the consensus of $10.2 million.
    • TAL Education Group (NYSE:TAL) rose 9.4% to close at $4.99.
    • MediciNova, Inc. (NASDAQ:MNOV) gained 8.9% to close at $2.56. MediciNova said the Phase 2 trial of MN-166 (ibudilast) in hospitalized COVID-19 patients demonstrated significant improvements compared to placebo for all four clinical endpoints analyzed.
    • Tiziana Life Sciences Ltd (NASDAQ:TLSA) climbed 8.3% to close at $0.7935. Tiziana Life Sciences announced second patient showed clinical improvements in the positron emission tomography imaging analysis, neurologic exam, and timed 25-foot walk test, following three months of treatment in secondary progressive multiple sclerosis trial.
    • Evolve Transition Infrastructure LP (NYSE:SNMP) rose 5.5% to close at $0.56 after the company announced court approval of Mesquite Energy, Inc. settlement agreement.


    Losers

    • Integrated Media Technology Limited (NASDAQ:IMTE) fell 67.5% to close at $3.65 on Wednesday.
    • Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) fell 60.2% to close at $0.7005 after the company announced data from the FORWARD Phase 3 clinical trial did not demonstrate statistical significance in the primary efficacy endpoint.
    • Phoenix Motor Inc. (NASDAQ:PEV) dipped 45.9% to close at $4.06. Phoenix Motor priced its initial public offering of 2.1 million shares at $7.50 per share.
    • Loyalty Ventures Inc. (NASDAQ:LYLT) shares tumbled 45.4% to close at $6.02 on Wednesday after the company said it will reevaluate its 2022 revenue and EBITDA guidance and said its AIR MILES reward program and AIR MILES' sponsor Sobeys were unable to align on extension terms.
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) dropped 35.7% to close at $0.74.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) shares fell 23.7% to close at $9.23 after jumping 155% on Tuesday. The FDA recently granted clearance for the company's pūrgo technology, classifying it as a class II medical device.
    • Cosmos Holdings Inc. (NASDAQ:COSM) fell 23.4% to close at $0.8201.
    • Odyssey Marine Exploration, Inc. (NASDAQ:OMEX) declined 21.4% to close at $2.53.
    • Microvast Holdings, Inc. (NASDAQ:MVST) fell 21.1% to close at $3.30.
    • Applied UV, Inc. (NASDAQ:AUVI) shares fell 18.8% to close at $1.77 after jumping 96% on Tuesday.
    • NantHealth, Inc. (NASDAQ:NH) dropped 15.9% to close at $0.53. NantHealth, last month, posted a Q1 loss of $0.11 per share.
    • AdTheorent Holding Company, Inc. (NASDAQ:ADTH) fell 15% to close at $6.00.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) declined 14.7% to close at $58.46.
    • HashiCorp, Inc. (NASDAQ:HCP) fell 14.5% to close at $32.76.
    • Cadre Holdings, Inc. (NYSE:CDRE) dropped 14.1% to close at $24.01. Cadre Holdings announced launch of public primary and secondary offering of 1.75 million of common stock.
    • Boxed, Inc. (NYSE:BOXD) fell 13.5% to close at $3.09. Boxed announced addition to the Russell 2000 index.
    • Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) declined 12.2% to close at $43.08 after the company reported a secondary offering of 2,000,000 shares held by Ziff Davis.
    • The Scotts Miracle-Gro Company (NYSE:SMG) fell 9.5% to $92.45 after the company cut its FY22 EPS guidance below analyst estimates.
    • The Singing Machine Company, Inc. (NASDAQ:MICS) dropped 9.2% to close at $3.57.
    • Matson, Inc. (NYSE:MATX) fell 8.9% to close at $93.13.
    • Smartsheet Inc. (NYSE:SMAR) shares fell 7% to close at $37.76 after the company issued Q2 adjusted EPS guidance below analyst estimates.
    • The Lovesac Company (NASDAQ:LOVE) fell 6.3% to close at $35.62 after the company reported Q1 financial results.
    Get the next $ACLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLX
    $ADTH
    $AERC
    $AMLX

    CompanyDatePrice TargetRatingAnalyst
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    TAL Education Group
    $TAL
    1/30/2026$18.00Neutral → Outperform
    Macquarie
    Alibaba Group Holding Limited
    $BABA
    1/21/2026$190.00Neutral → Buy
    Arete
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$231.00 → $225.00Buy
    Jefferies
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$200.00 → $180.00Overweight
    Morgan Stanley
    Arcellx Inc.
    $ACLX
    1/7/2026$100.00Buy
    UBS
    Limoneira Co
    $LMNR
    12/31/2025$19.00Buy
    Lake Street
    Arcellx Inc.
    $ACLX
    12/22/2025$100.00Overweight
    Wells Fargo
    More analyst ratings

    $ACLX
    $ADTH
    $AERC
    $AMLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for LEVOFLOXACIN issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug LEVOFLOXACIN (SUPPL-11) with active ingredient LEVOFLOXACIN has changed to 'Approval' on 09/20/2024. Application Category: ANDA, Application Number: 205222, Application Classification: Labeling

    9/24/24 4:39:48 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MYCOPHENOLATE MOFETIL issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug MYCOPHENOLATE MOFETIL (SUPPL-7) with active ingredient MYCOPHENOLATE MOFETIL has changed to 'Approval' on 08/13/2024. Application Category: ANDA, Application Number: 214525, Application Classification: REMS

    8/15/24 4:43:42 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SKYX Announces Launch at Home Depot of its Ceiling Plug & Play SKYFAN & TURBO HEATER, including a Launch of a Dedicated SkyPlug Branding Page at HomeDepot.com

    The New SkyPlug Dedicated Brand Page for SKYX's Product on HomeDepot.com Supports Product Education, Awareness, and Scalable Growth Company Anticipates Significant Growth for its Turbo Heater and Ceiling Fan Models in Home Depot Channel During 2026 Launch Expands SKYX's Retail Footprint and Positions the Company for Increased Consumer Reach in 2026 The Ceiling Fan and Space Heater Categories Represent a Multi-Billion-Dollar Annual Market in North America MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive smart home platform technology company with over 100 pending and issued patent

    2/6/26 9:28:14 AM ET
    $SKYX
    Building Products
    Consumer Discretionary

    TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

    NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual forum, being held in San Diego, California. Links to each presentation are included below. Michael S. Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated, "We are pleased to share data at this year's ACTRIMS annual meeting, including updates from the ENABLE real world study evaluating patients with RMS on BRIUMVI. Our presentations reflect our continued focus on advancing the clinical understanding of

    2/6/26 7:30:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HUTCHMED to Announce 2025 Final Results

    HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December 31, 2025 on Thursday, March 5, 2026 at 6:00 am Eastern Standard Time (EST) / 11:00 am Greenwich Mean Time (GMT) / 7:00 pm Hong Kong Time (HKT). HUTCHMED management will host two webcast presentations for analysts and investors to discuss the final results, followed by Q&A sessions. The English webcast will be held on Thursday, March 5, 2026, at 8:00 am EST (1:00 pm GMT / 9:00 pm HKT). The Chinese (Putonghua) webcast will be held at 8:30 am HKT / 12:30 am GMT on Friday, March 6, 202

    2/6/26 3:30:00 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Heyer Andrew R was granted 279 shares, increasing direct ownership by 0.11% to 250,643 units (SEC Form 4)

    4 - Lovesac Co (0001701758) (Issuer)

    2/5/26 5:55:11 PM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    Director Kingdon Mark D converted options into 165 shares, increasing direct ownership by 1% to 11,658 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/5/26 11:56:22 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Director Hanft Adam converted options into 336 shares, increasing direct ownership by 0.75% to 45,018 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/5/26 11:56:28 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $175,000 worth of shares (353,321 units at $0.50), increasing direct ownership by 5% to 8,091,795 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/21/26 10:11:57 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $220,000 worth of shares (493,495 units at $0.45), increasing direct ownership by 7% to 7,738,474 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/15/26 9:40:58 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Plus Therapeutics with a new price target

    Lake Street initiated coverage of Plus Therapeutics with a rating of Buy and set a new price target of $2.00

    2/3/26 8:52:26 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    TAL Education upgraded by Macquarie with a new price target

    Macquarie upgraded TAL Education from Neutral to Outperform and set a new price target of $18.00

    1/30/26 6:41:31 AM ET
    $TAL
    Other Consumer Services
    Real Estate

    Alibaba upgraded by Arete with a new price target

    Arete upgraded Alibaba from Neutral to Buy and set a new price target of $190.00

    1/21/26 8:25:13 AM ET
    $BABA
    Real Estate

    $ACLX
    $ADTH
    $AERC
    $AMLX
    SEC Filings

    View All

    SEC Form 6-K filed by MINISO Group Holding Limited

    6-K - MINISO Group Holding Ltd (0001815846) (Filer)

    2/6/26 8:00:17 AM ET
    $MNSO
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

    2/6/26 6:06:10 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Limoneira Co filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Limoneira CO (0001342423) (Filer)

    2/5/26 4:32:37 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Leadership Updates

    Live Leadership Updates

    View All

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Limoneira Announces Chief Financial Officer Succession

    Greg Hamm to Succeed Mark Palamountain as Chief Financial Officer Limoneira Company (the "Company" or "Limoneira") (NASDAQ:LMNR), a diversified lemon and avocado growing and lemon packing company with related agribusiness activities and real estate development operations, today announced that Mark Palamountain will step down from his role as Chief Financial Officer to pursue interests outside of the Company.​ Greg Hamm, who has served as Corporate Controller since 2004 and as Vice President and Corporate Controller since 2008, will succeed Palamountain as Chief Financial Officer. The effective date of Palamountain's departure and Hamm's appointment has not been determined and Palamountain

    1/28/26 4:05:00 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Coro Appoints Eyal Hen as Chief Financial Officer

    Veteran public-company finance leader joins Coro to support global scale and the company's next phase of growth Coro, the leading cybersecurity platform for Lean IT-driven organizations, today announced the appointment of Eyal Hen as its new Chief Financial Officer, effective immediately. Hen will oversee Coro's global finance organization as the company accelerates international growth and continues building the financial foundation to support its next stage of scale. "As Coro grows globally, we're deliberately investing in leadership that brings exactly what we need right now: public-company financial discipline combined with operational experience scaling global teams," said Joe Syko

    1/21/26 9:00:00 AM ET
    $REKR
    Telecommunications Equipment
    Telecommunications

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Financials

    Live finance-specific insights

    View All

    TAL Education Group Announces Unaudited Financial Results for the Third Fiscal Quarter Ended November 30, 2025

    BEIJING, Jan. 29, 2026 /PRNewswire/ -- TAL Education Group (NYSE:TAL) ("TAL" or the "Company"), a smart learning solutions provider in China, today announced its unaudited financial results for the third quarter of fiscal year 2026 ended November 30, 2025. Highlights for the Third Quarter of Fiscal Year 2026 - Net revenues were US$770.2 million, compared to net revenues of US$606.4 million in the same period of the prior year. - Income from operations was US$93.1 million, compared to loss from operations of US$17.4 million in the same period of the prior year. - Non-GAAP income from operations, which excluded share-based compensation expenses, was US$104.0 million, compared to non-GAAP loss

    1/29/26 4:00:00 AM ET
    $TAL
    Other Consumer Services
    Real Estate

    ScottsMiracle-Gro Reports First Quarter Results and Advancement of Key Strategic Initiatives

    Announces divestiture plan for Hawthorne Unveils new multi-year share repurchase program to commence in late 2026 MARYSVILLE, Ohio, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE:SMG), the leading marketer of branded consumer lawn and garden products in North America, today reported results for the first quarter ended December 27, 2025. The Company also announced that it is in advanced discussions for the sale of its Hawthorne subsidiary to Vireo Growth, Inc., with an anticipated closing in the fiscal second quarter. In conjunction with the pending divestiture, effective in its first quarter of fiscal 2026, the Company classified its results of operations for all

    1/28/26 7:00:00 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Youdao to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11

    HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced that it will report its fourth quarter and fiscal year 2025 financial results on Wednesday, February 11, 2026, before the open of the U.S. markets. The earnings teleconference call with simultaneous webcast will take place at 5:00 a.m. Eastern Time on Wednesday, February 11, 2026 (Beijing/Hong Kong Time: 6:00 p.m., Wednesday, February 11, 2026). Youdao's management will be on the call to discuss the quarterly results and answer questions. Dial-in d

    1/28/26 3:30:00 AM ET
    $DAO
    $NTES
    Other Consumer Services
    Real Estate
    Computer Software: Prepackaged Software
    Technology

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance